Genetic blueprint of the zoonotic pathogen Toxocara canis by Zhu, Xing-Quan et al.
ARTICLE
Received 16 Aug 2014 | Accepted 11 Dec 2014 | Published 4 Feb 2015
Genetic blueprint of the zoonotic pathogen
Toxocara canis
Xing-Quan Zhu1,2,*, Pasi K. Korhonen2,*, Huimin Cai3,*, Neil D. Young2, Peter Nejsum4,
Georg von Samson-Himmelstjerna5, Peter R. Boag6, Patrick Tan7,8, Qiye Li3, Jiumeng Min3, Yulan Yang3,
Xiuhua Wang3, Xiaodong Fang3, Ross S. Hall2, Andreas Hofmann9, Paul W. Sternberg10,
Aaron R. Jex2 & Robin B. Gasser2
Toxocara canis is a zoonotic parasite of major socioeconomic importance worldwide.
In humans, this nematode causes disease (toxocariasis) mainly in the under-privileged
communities in developed and developing countries. Although relatively well studied from
clinical and epidemiological perspectives, to date, there has been no global investigation of
the molecular biology of this parasite. Here we use next-generation sequencing to produce a
draft genome and transcriptome of T. canis to support future biological and biotechnological
investigations. This genome is 317Mb in size, has a repeat content of 13.5% and encodes at
least 18,596 protein-coding genes. We study transcription in a larval, as well as adult female
and male stages, characterize the parasite’s gene-silencing machinery, explore molecules
involved in development or host–parasite interactions and predict intervention targets. The
draft genome of T. canis should provide a useful resource for future molecular studies of this
and other, related parasites.
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P
arasitic worms have a devastating, long-term impact on
human health worldwide. For instance, approximately two
billion people are infected with soil-transmitted helminths,
such as hookworms (Necator and Ancylostoma), whipworm
(Trichuris) and the large roundworm (Ascaris), principally in
under-privileged areas of Latin America, Africa and Asia1. The
global disease burden caused by these parasites is comparable
with that of tuberculosis and malaria in disability-adjusted life
years1. Ascaris, for example, infects more than one billion people,
causing nutritional deﬁciency, impaired cognitive and physical
development, principally in children and, in severe cases, death2.
Published information3,4 also shows that a related parasite,
Toxocara canis (Werner, 1782), infects millions of people in
poverty-stricken parts of the USA alone. Toxocariasis, the disease
caused by Toxocara spp., is highly prevalent in many developing
countries, where its importance is likely to be seriously
underestimated. Toxocariasis results from zoonotic transmission
of Toxocara spp. from carnivores, including canids and felids5,6.
T. canis of canids is recognized as the main causative agent of
zoonotic disease; this species has a complex life cycle, which can
also involve paratenic hosts such as rodents. In humans,
particularly children, T. canis larvae invade various tissues
to cause visceral larva migrans, ocular larva migrans,
neurotoxocariasis (including eosinophilic meningoencephalitis)
and/or covert toxocariasis7. In addition, clinical and experimental
studies8,9 have indicated an association between T. canis infection
and allergic disorders, such as asthma, chronic pruritus and
urticaria. Both the canine and mouse models of T. canis10,11
represent important tools for studies of the biology of the
parasite, parasite–host interactions and toxocariasis at the
immuno-molecular level.
To facilitate such investigations, we sequenced and annotated
the 317Mb draft genome of T. canis and compare it with other
nematode genomes. This genome contains at least 18,596 protein-
coding genes, whose predicted products include at least 373
peptidases, 458 kinases, 408 phosphatases, 273 receptors and
530 transporters and channels. Notably, the T. canis secretome
(870 molecules) is rich in peptidases proposed to be associated
with the penetration and degradation of host tissues, and an
assemblage of molecules suggested to modulate or suppress host-
immune responses. This genome should provide a useful resource
to the scientiﬁc community for a wide range of post-genomic
studies of T. canis and could support the development of
new interventions (drugs, vaccines and diagnostics) against
toxocariasis and related nematodiases.
Results
Genome assembly and repeat content. We sequenced the
T. canis genome at 110-fold coverage and produced a ﬁnal draft
assembly of 317Mb (N50¼ 375 kb; Table 1) with a mean GC
content of 40.0% (5.8% Ns). We detected 98.4% of the 248 core
eukaryotic genes by Core Eukaryotic Genes Mapping Approach
(CEGMA), indicating that the assembly represents a substantial
proportion of the entire genome. We estimated a repeat content
in this draft genome of 13.5% (equating to 42.9Mb of DNA),
comprising 1.8% DNA transposons, 4.1% retrotransposons,
1.4% unclassiﬁed dispersed elements and 6.4% simple repeats
(Supplementary Data 1); the overall repeat content is similar
to that of the germline genome of the related worm Ascaris
suum, but considerably higher than its somatic (diminuted)
genome12,13. We identiﬁed 72,862 distinct retrotransposon
sequences (see Supplementary Data 1) representing at least 68
families (16 LTR, 32 LINE and 20 SINE), with Gypsy, Pao and
Copia predominating for LTRs (n¼ 12,436, 4,859 and 1,302,
respectively) and CR1, RTE-RTEand L2 for non-LTRs
(n¼ 16,073, 8,550 and 7,696, respectively). We also identiﬁed
61 families of DNA transposons (a total of 45,249 distinct
sequences), of which CMC-EnSpm, Novosib and MULE-MuDR
(n¼ 19,762, 2,787 and 2,501, respectively) predominated. This
richness of families of transposable elements is comparable with
that of genomes of other parasitic nematodes12,14,15.
The gene set of T. canis and comparison with other nematodes.
Using transcriptomic data from adult and larval stages of T. canis,
de novo predictions and homology-based searching, we identiﬁed
18,596 coding genes, with mean gene, exon and intron lengths of
8,416, 156 and 1,133 bp, respectively, and an average of 7.4 exons
per gene (Table 1), similar to the ﬁndings for our Ascaris gen-
ome12. Compared with the draft genome sequences of A.
suum12,13, Brugia malayi14, Caenorhabditis elegans16 and
Pristionchus paciﬁcus15, on average, the T. canis genes have
most sequence similarity to those of A. suum and are signiﬁcantly
longer than in the genomes of the other four nematodes, likely
relating to an increased number and length of exons
(Supplementary Data 2). Most (67.5%) of the predicted T. canis
genes (Fig. 1) have an ortholog (BLASTp cut-off: 10 5) in A.
suum (n¼ 11,658; 62.7%), B. malayi (8,395; 45.1%), C. elegans
(9,002; 48.4%) or P. paciﬁcus (7,968; 42.8%). A total of 5,918
genes are orthologous among all 5 species, 3,557 are shared with
at least 1 other species of nematode but absent from C. elegans
and 1,925 are shared exclusively with Ascaris to the exclusion of
the other 3 nematodes (Fig. 1). Conversely, 6,037 genes (32.5%)
are unique to T. canis relative to the other 4 nematodes (Fig. 1).
Table 1 | Summary of the features of the Toxocara canis draft
genome.
Description
Genome size (bp) 317,115,901
Number of scaffolds; contigs 22,857; 51,969
N50 (bp); count42 kb in length 375,067; 2,899
N90 (bp); count4N90 length 66,363; 938
Genome GC content (%) 40.0
Repetitive sequences (%) 13.5
Exonic proportion; including introns (%) 6.8; 49.4
Number of putative coding genes 18,596
Mean gene size (bp) 8,416
Mean CDS length (bp) 1,156
Mean exon number per gene 7.4
Mean exon length (bp) 156
Mean intron length (bp) 1,133
Coding GC content (%) 47.4
CEGMA completeness: complete; partial (%) 67.3; 98.4
T. canis
C. elegans
B. malayi
P. pacificus
A. suum
6037
155
59174
37 108 143225
1925 168 257 5918 1112
4361071771
Figure 1 | Gene orthology. Venn diagram showing the number of orthologs
between Toxocara canis and four other nematode species, Ascaris suum,
Brugia malayi, Caenorhabditis elegans and Pristionchus paciﬁcus upon pairwise
comparison.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7145
2 NATURE COMMUNICATIONS | 6:6145 |DOI: 10.1038/ncomms7145 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
Of the entire T. canis gene set, 5,406 genes (29.1%) have an
ortholog (r10 8) linked to known biological pathways (Kyoto
Encyclopaedia of Genes and Genomes (KEGG); Supplementary
Data 3). Mapping to pathways in C. elegans suggested a near
complete complement of KEGG orthology groups (90.6%), also
supporting the CEGMA results. By inference, most T. canis genes
are represented in the present genomic assembly; at least 17,208
of all the 18,596 genes predicted here are supported by extensive
transcriptomic and/or inferred proteomic data.
Functional annotation and protein classiﬁcations. In total,
14,583 (78.4%) of the protein sequences predicted from the
18,596 coding genes of T. canis were annotated based on the
presence of characteristic protein domains (Supplementary
Data 4); 12,346 (66.4%) matches were found in C. elegans,
and 10,977 (59.0%), 10,556 (56.8%) and 13,905 (74.8%) had
signiﬁcant matches in the InterProScan, Swiss-Prot and KEGG
databases, respectively. Of the 10,977 InterPro matches, 9,121
(83.1%), 10,494 (95.6%), 1,827 (16.6%) and 412 (3.8%) were in
Pfam, PANTHER, PRINTS and PIRSF databases, respectively.
According to the KEGG BRITE hierarchy, predicted proteins
represented peptidases (n¼ 373), kinases (458), phosphatases
(408), receptors (273), transporters (530), GTPases (127), ion
channels (268) and transcription factors (355); (Supplementary
Data 5), with some proteins inferred to have multiple functions.
Key enzymes, channels, pore and transporters. We identiﬁed
ﬁve main classes of peptidases (metallo-, cysteine, serine, threo-
nine and aspartic), with the metallo- (n¼ 165; 44.2%), cysteine
(107; 28.7%) and serine (60; 16.1%) proteases predominating
(Supplementary Data 5). The most abundant families in these
classes are the M12 astacins and adamalysins (n¼ 57), M01
aminopeptidases (19) and M13 neprilysins (13) among the
metallo proteases; the C19 ubiquitin-speciﬁc proteases (n¼ 30),
C01 papains (that is, cathepsins; 16) and C02 calpain-like
enzymes (16) among the cysteine proteases; and the S01 ‘chy-
motrypsins’ (n¼ 12), S09 prolyl oligopeptidases (12) and S08
subtilisins (9) among the serine proteases. These secreted pepti-
dases (for example, the M12 metallo, the C01 and C02 cysteine, as
well as the S01, S08 and S09 serine proteases) are of major
interest, given their presence in the excretory/secretory (ES)
products of many parasitic helminths, and their central roles in
tissue degradation and invasion (for example, during migration
and/or feeding) and/or in immune evasion or modulation17,18. ES
peptidases (including aminopeptidases and/or cysteine proteases)
are likely to play key roles in these processes in T. canis and might
represent important drug or vaccine targets.
We also identiﬁed 458 protein kinases and 408 phosphatases in
T. canis (Supplementary Data 5). The kinome includes a large
portion of serine/threonine protein (67.2%) and tyrosine (13.3%),
as well as a small number of atypical or unclassiﬁed kinases
(19.4%). The phosphatome includes predominantly serine-
threonine (81.1%), protein tyrosine (12.7%) and a minority of
other phosphatases. On the basis of the homology to molecules in
the KEGG orthology (KO) database, we found 127 GTPases to be
encoded in the T. canis genome, including 29 large (hetero-
trimeric) and 98 small (monomeric) G-proteins representing the
Rab (n¼ 42), Ras (19), Arf/Sar (16), Rho (16) and Ran (1)
families, as well as some unclassiﬁed molecules. Examples of these
include C. elegans homologues eft-1 (gene Tcan_11808), fzo-1
(Tcan_14313), glo-1 (Tcan_03008) and rho-1 (for example,
Tcan_13740; cf. Supplementary Data 5), which play essential
roles in embryonic, larval and/or reproductive development and
are also found in Ascaris12. Therefore, some of these enzymes
might be targets for anti-parasite interventions.
Also of interest in this context is the panel of channel, pore and
transporter proteins that we identiﬁed here, particularly con-
sidering that many common anthelmintics bind representatives
of some of these proteins as targets19. We predicted 156 GPCRs
to be encoded in T. canis; these include 111 class A rhodopsin
family (for example, neuropeptide, serotonin, acetylcholine,
dopamine and adrenaline receptors), 21 class B secretin
receptor family (for example, parathyroid hormone, nematode
chemoreception and latrophilin receptors), 10 class C
metabotropic glutamate/pheromone family (for example,
glutamate and gamma-aminobutyric acid (GABA) receptors)
and 14 other (for example, Wnt) receptors (Supplementary
Data 5). In addition, of the 530 transporters predicted here, we
identiﬁed an abundance of those of the solute carrier family
(67.2%), major facilitator superfamily, ABC transporters (10.8%;
including P-glycoproteins) and major facilitator superfamily
(3.4%)20,21. In addition, we identiﬁed 268 ion-channel proteins
(Supplementary Data 5), the majority of which represented the
Cys-loop superfamily (including nicotinic, glycine, aniononic and
GABA-A; 39.6%), as well as voltage-gated cation (mainly Kþ
channels, including SLO-1; 31.0%) and others related to voltage-
gated cation channels (transient receptor potential; 10.8%), some
of which are known targets for anthelmintic drugs22.
Stage-, gut- and gender-enriched transcription proﬁles. Here
we deﬁned clusters of genes that are signiﬁcantly differentially
transcribed between the T. canis adult and third-stage larvae (L3s
from fully embryonated eggs), and between the two sexes of this
nematode, by integrating data from KO enrichment, as well as co-
transcription and functional network analyses (Supplementary
Data 6–9). In the T. canis life cycle, dioecious adults establish and
live in the small intestine of the canid host following hepato-
pulmonary migration of parasitic L3s11. By comparison to L3, we
showed that pathways enriched in the adult stage involve carbon
metabolism (for example, aldo-2, c04c3.3, enol-1, fbp-1, gpd-3 and
gpi-1), lysosome activity, transport (ABC transporters),
xenobiotic metabolism and DNA replication/repair, likely
linked to digestive and reproductive processes in the worm
(Fig. 2 and Supplementary Data 4, 6 and 7). With reference to the
adult stage, L3-enriched pathways were mostly linked to neuronal
signalling (for example, ckr-2, dop-1, gar-2 and unc-49), and
cuticle formation and/or shedding (including col-121, dpy-5 and
sqt-1; Fig. 2 and Supplementary Data 4, 6 and 7) which might
relate to ‘‘fuzzy coat’’ shedding from L3s during immune attack
in vitro23,24. Interestingly, homologues of various genes known to
regulate dauer in C. elegans were upregulated (for example, daf-9,
daf-12, osm-3 and osm-6) or downregulated (two paralogs of mek-
2) in the L3 stage25,26 (Fig. 2), which supports the proposal that
this stage is in an arrested state of development following the
in vitro-hatching of embryonated eggs and maintenance in
culture in the absence of host factors24.
In addition, in the worm, we showed that the intestinal tract of
T. canis was speciﬁcally enriched for gene transcripts linked to
molecular uptake and degradation via lysosomes (for example,
vha-2, -4, -6, -8 and -12), the transportation of amino acids,
sugars, lipids and drugs, the metabolism of xenobiotic metabo-
lism (for example, ugt-22, -34, -45, -49, -63 and cyp14a5), as well
as protein digestion (aspartic, cysteine and metallo-peptidases)
and fatty acid elongation (for example, elo-2, -3, -4, -5, -6 and -9;
Fig. 2 and Supplementary Data 4, 6 and 7). These processes are
consistent with extensive digestive, absorptive and detoxifying
functions within the gut of T. canis and similar, in some respects,
to those suggested for Ascaris27.
Given the size of adult T. canis (usually 5–15 cm in length),
we were able to investigate differential transcription between
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individual female and male worms. Genes with female-enriched
transcription were linked to signal transduction pathways
involving mainly neuroactive GABA glycine and acetycholine
receptors, as well as G protein-coupled receptors associated
with germ cell proliferation and embryogenesis (Fig. 2 and
Supplementary Data 4, 6 and 7). Female-enriched transcription
related to genes encoding glycosyltransferases of N-acetyl
glucose/galactosamine moieties linked to egg shell synthesis in
oogenesis (for example, gene codes C36A4.4, F07A11.2 and
F21D5.1), oocyte maturation and embryonic development (for
example, ceh-13, elt-3, gsk-3, kgb-1, nrh-1, pha-4, rab-11.1, unc-60,
-130 and vab-2), egg laying (for example, lin-29, nsy-1, rhgf-1,
sem-2 and sox-2) and vulva development (for example, arf-1.2,
ceh-20, let-23, lin-1 and -61; Fig. 2 and Supplementary Data 4,
6 and 7). In contrast, genes with male-enriched transcription were
inferred to be associated with protein degradation, spermatogen-
esis, epinephrine-like hormone regulation (tyramine and octopa-
mine) and energy metabolism (Fig. 2 and Supplementary Data
4, 6 and 7). Key genes with male-enriched proﬁles encoded
proteasome-related enzyme groups as well as protein-serine/
threonine and -tyrosine kinases linked to sperm and spermato-
genesis. Conspicuous were those linked to the 26S proteasome
and associated recycling of ubiquitin moieties (for example, pas-1,
rpn-1, rps-26, rtp-3 and rpt-5) involved in germline development
and spermatogenesis (for example, cpb-1, fog-3 and spe-6; Fig. 2
and Supplementary Data 4, 6 and 7). Overall, of all 3,760 genes
exhibiting gender-enriched transcription, B26% had no
homologues in any other organisms for which genomic or
transcriptomic data are publicly available.
The secretome and molecules for parasite–host interactions.
We predicted the secretome of T. canis to comprise at least 870
ES proteins with a diverse array of functions (Supplementary
Data 10). Most notable are at least 14 peptidases, including 7 SC
serine proteases (S1, S9 and S28 families), 3 aspartic proteases (A1
family), 3 CA/CD cysteine proteases (C1 and C13 families) and 1
MA metallo-protease (M14 family), as well as 23 cell-adhesion
molecules (immunoglobulins, integrins and cadherins), 17 lectins
(C-type) and 6 SCP/TAPS proteins (venom allergen homo-
logues)28. Many secreted peptidases (representing the
‘degradome’) and their respective inhibitors have known roles
in the penetration of tissue barriers and feeding by parasitic
worms, including T. canis5,23.
T. canis larvae invade various tissues, including muscles, brain
and eyes, and cause clinical disease. Such larvae have an
exceptional ability to evade or block host attack and can survive
for many years in tissues. This ability is associated with the
deployment of molecules excreted or secreted by the parasite or
released from its surface coat23,24. Here, we predicted 33 proteins
involved in host interactions and/or modulating host immune
responses (Supplementary Data 11). Abundant in O-linked
glycosylations are mucins (n¼ 7), many of which are likely
heavily targeted by IgM antibodies and bound by various pattern-
recognition receptors associated with host dendritic cells,
responsible for inducing a Th2 immune response18.
Immunomodulatory molecules predicted in T. canis also
include homologues (E-value cut-off¼ 10 8) of the B. malayi
cystatin CPI-2 (B-cell inhibitor), several transforming growth
factor-b and macrophage initiation-factor mimics, numerous
neutrophil inhibitors, oxidoreductases, known to counteract the
neutrophil oxidative burst, and ﬁve close homologues of platelet
anti-inﬂammatory factor-a18. Key examples of T. canis ES
proteins predicted to be involved in immune evasion include
some ‘hidden’ antigens29 (for example, numerous C-type lectins)
with close homology to vertebrate macrophage mannose or CD23
(low afﬁnity IgE) receptors, which mimic host molecules18.
Other representatives include mucins (originating from the
parasite’s surface coat), phosphatidylethanolamine-binding
proteins, cathepsins, asparagyl endopeptidases (legumains),
superoxide dismutases, SCP/TAPS28, olfactomedin, aquaporin,
prohibitin and various orphan proteins (including abundant new
transcripts (ANTs)), identiﬁed previously in small-scale
molecular studies of T. canis23,24. Interestingly, although not
encoded in the genome, ants-3, -5, -30 and -34 were transcribed
at very high levels in all tissues of one of four female T. canis
studied here and at high levels in all L3 samples, but were
transcribed at very low levels or not at all in tissues of the adult
males (Supplementary Data 11). Three-dimensional modelling of
all predicted ANTs showed that ANT-5 is an RNA-dependent
RNA polymerase and that ANT-34 is a RNA helicase, consistent
with previous ﬁndings30. The absence of the ant genes from the
draft genome, the similarity in the structures of ANT-5 and
ANT-34 with viral proteins and the inconsistency in their
transcription in stages, sexes and/or tissues of T. canis suggest
that ant transcripts are derived from one or more double-
stranded-RNA viruses. This proposal warrants investigation to
establish whether ANTs are crucial to the biology of T. canis and
indeed have a role in regulating transcription30. Overall, the
present genomic and transcriptomic data sets reveal that, on a
global scale, T. canis possesses a major arsenal of ES proteins that
are involved in manipulating, blocking and/or evading immune
responses in host animals. A detailed understanding the roles of
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Figure 2 | Stage-, gut- and gender-enriched transcription. Key biological
pathways or processes in Toxocara canis, for which the gene transcription is
enriched in adult females (red) and males (blue); in adults and third-stage
larvae (L3; grey); and in the alimentary tract of the adult worms (black box,
top left). Molecules enriched in L3s and involved in parasite–host
interactions, such as immunomodulation, are also indicated (black box,
bottom left; ANT, abundant new transcripts); the number of genes with
signiﬁcantly increased transcription are given in parentheses. The proposed
arrested or dauer status of the L3 stage of T. canis (from embryontated
eggs) is supported by the transcription proﬁles (heat-map, right) for gene
homologues daf-9, daf-12 and osm-3, osm-6 (upregulation; yellow) and two
mek-2 paralogs (downregulation; orange to red), which are all known to
promote dauer in C. elegans; the biological replicates (1–4) studied are
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these molecules could pave the way to new intervention strategies,
such as vaccination.
New intervention targets and molecular function. Given that
only a small number of drugs are effective against toxocariasis in
accidental (human) or paratenic hosts31, there is a need for
improved treatments. In particular, genomic-guided drug-target
discovery provides an alternative means to conventional
screening and re-purposing32. The goal of such discovery is to
predict (essential) genes or gene products, whose inactivation by
one or more drugs selectively kills the nematode but does not
harm the mammalian host. Essentiality can be inferred from
functional information (for example, lethality) in
C. elegans33,34, and this approach has already yielded credible
targets in nematodes35. Here, in T. canis, we predicted 715
essential orthologs, of which 703 were linked to lethal-gene
knock-down phenotypes in C. elegans (Supplementary Data 12),
of which 230 had ligands that met the Lipinsky rule-of-ﬁve36,37
(Table 2 and Supplementary Data 12). Using stringent criteria, we
identiﬁed eight channels or transporters (including GABA,
acetylcholine receptors and SLO-1 calcium-activated potassium
channels), already recognized as targets for various anthelmintics,
including AADs, cyclic depsipeptides, imidazothiazole derivatives
(including levamisole) or macrocyclic lactones19,22,38,39. Also
notable are 57 kinases, 21 peptidases, 14 phosphatases (including
PP1 and PP2A homologues, as speciﬁc targets for norcantharidin
analogues)40, 5 GTPases and 4 GPCRs (Table 2). The validity of
these prioritized targets can now be tested on T. canis in vitro by
gene silencing, and subsequently with drugs.
Although stages of the parasite cannot be produced in culture,
L3s of T. canis can be maintained in vitro in serum-free medium
for extended periods (at least 18 months)41, suggesting that this
stage might be amenable to gene silencing by double-stranded-
RNA interference (RNAi) or using speciﬁc inhibitors. In total, we
identiﬁed 43 essential effector genes to be linked to the RNAi
pathway of T. canis (Supplementary Data 13), complementing the
information for nematodes42. Compared with A. suum, we found
the genes pash-1 and rde-4, encoding small RNA biosynthetic
proteins, as well as the nuclear RNAi effector gene ekl-1 in T.
canis. However, we detected neither the RNAi inhibitor nor the
effector genes adr-2 and gﬂ-1, respectively, in this nematode. We
identiﬁed a full repertoire of genes encoding argonautes,
including nrde-3. The genes encoding small interfering RNA
ampliﬁcation effectors as well as dsRNA uptake and spreading
factors were consistent with those in A. suum42, except sid-1
which is present in T. canis. All of the effectors identiﬁed were
transcribed in the gut and tissues of adult females and males of T.
canis. Argonautes were particularly highly transcribed in adult
worms compared with third-stage larvae (L3). The apparent
absence of the sid-2 gene suggests that the uptake of extracellular
dsRNA is compromised43. Some evidence indicating that gene
knock-down can be achieved in larvae of A. suum44,45 shows
promise for functionality testing of conserved and also orphan
(‘parasite-speciﬁc’) genes in T. canis larvae. Following extensive
work, compounds rationally designed to selected targets could be
tested and assessed in vivo in experimentally infected animals (for
example, dogs or mice).
Discussion
High throughput nucleic acid sequencing and bioinformatic
approaches are having far-reaching implications for investigating
socioeconomically important parasites. The present genomic and
transcriptomic exploration provides a global insight into the
molecular biology of T. canis, a zoonotic parasite of major animal
and human health importance worldwide. We predicted
molecules involved in host–parasite interactions and immune
responses, and studied transcriptional differences between two
stages and sexes, as well as the gut of the adult stage of the
parasite. The present draft genome and transcriptomes of T. canis
should accelerate post-genomic explorations. For instance, a
systems biology-based approach should now facilitate many
aspects of the developmental and reproductive biology, molecular
biology and biochemistry of T. canis, as well as parasite–host
interactions and the pathogenesis of toxocariasis to be explored,
also based on the knowledge of homologs/orthologs and
information in curated, public databases. The characterization
of the RNAi machinery in of T. canis could provide a solid
platform for fundamental, functional genomic work in selected
stages (for example, cultured larvae) of the parasite. Technolo-
gical advances also provide prospects for large-scale investigations
of the proteome and metabolome of T. canis. In addition, the use
of advanced glycomic methods46 should provide profound
insights into the often heavily glycosylated proteins in Toxocara
ES products5,23,24. Clearly, the present genome and
transcriptomic data provide the critical resources to enable the
transition from ‘single-molecule’ research to global molecular
discovery in T. canis. This exciting prospect could lead to a
paradigm shift in our understanding of this enigmatic parasite
and to signiﬁcant advances in applied areas, including the
development of drugs, vaccines and diagnostic tests. Although
this study focused on T. canis, the ﬁndings and the technological
approaches used should be readily applicable to a wide range of
other ascaridoid nematodes of major animal and human health
importance.
Methods
Procurement of T. canis. Fresh specimens of T. canis (adults) expelled from a
naturally infected domestic dog and faeces from the same, infected dog were given
to one of us (P.N.) by a dog owner from Næstved, Denmark. Worms and eggs were
identiﬁed morphologically47. Eggs were isolated from the faeces by sieving (mesh
sizes: 500, 200, 90 and then 60 mm) and puriﬁed by sugar-salt ﬂotation48, washed in
water and then allowed to fully embryonate in H2SO4
(pH 2.0) at 22 C for 30 days. L3s were released from within their egg shells by
glass-bead (400 mm) beating for 40min (37 C), concentrated for 3 h at 37 C in 5%
CO2 in a Baermann funnel49; then, L3s were washed extensively in sterile saline,
pelleted and snap-frozen in liquid nitrogen. Adult stages of T. canis were washed
extensively in saline (37 C), sexes separated and then snap-frozen individually and
stored at  80 C until use; the speciﬁc identity of each specimen was veriﬁed by
PCR-based sequencing of the second internal-transcribed spacer of nuclear
ribosomal DNA (NCBI accession identiﬁer Y09489)50.
Genomic DNA, library construction and sequencing. High molecular weight
genomic DNA was isolated from a single immature adult male of T. canis using a
Table 2 | Druggable candidates represented in the Toxocara canis genome.
Protein Subtype (number) Total number
GTPases Small GTPase (5) 5
Kinases TK (5); AGC (9); CAMK (6); CMGC (13); STE (6); TKL (3); other (11) 57
Peptidases A1 (1); C1/2/19/28/44 (3/1/1/1/1); M24/12/2/14/1 (2/2/1/1/1); S8/14/28 (1/1/1); T1 (3) 21
Phosphatases PPPs (11); class I PTPs (3) 14
Transporters and channels ABCB/ABCC (1/1); DUOX (1); GABA-A (1); acetylcholine (1); glutamate (1) 6
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commercial kit (Chemagic STAR DNA Tissue Kit, Perkin Elmer) according to the
manufacturer’s protocol. The DNA yield was measured spectrophotometrically
(Qubit ﬂuorometer dsDNA HS Kit, Invitrogen); DNA integrity was veriﬁed by
agarose-gel electrophoresis and using a Bioanalyzer (2100, Agilent). Paired-end
(PE) genomic libraries (with 170-, 500- and 800-bp inserts) as well as jumping (J)
genomic libraries (with 2-, 5-, and 10-kb inserts) were constructed according to
manufacturer’s instructions (Illumina); to produce sufﬁcient amounts of DNA for
these latter libraries, 250–500 ng of genomic DNA were subjected to whole-genome
ampliﬁcation using the REPLI-g midi kit (Qiagen), as recommended. All sequen-
cing was carried out on GA II or HiSeq (Illumina; 2 75 or 2 100 reads for
paired-end libraries, and 2 49 reads for J-libraries), and reads were exported to
the FASTQ format.
RNA isolation and RNA-seq. RNA was isolated separately from different
developmental stages and body parts of T. canis (three biological replicates of L3s;
and four replicates of each female and male reproductive tracts; female and male
anterior bodies; female and male guts) employing TriPure (Roche Molecular
Biochemicals). For L3s, packed volumes of 20–50 ml were used, equating to
thousands of larvae. For other stages and components, packed volumes of
100–200 ml from single worms were used. RNA yields were estimated spectro-
photometrically (NanoDrop 1000), and integrity was veriﬁed using a Bioanalyzer.
RNA-seq was carried out according to manufacturer’s instructions (Illumina).
Pre-processing of sequence reads. Genomic and RNA-seq reads derived from
individual libraries were assessed for quality, adaptors removed and sequencing
errors corrected using an in-house pipeline. Then, any dog (Canis lupus familiaris;
host of T. canis) and bacterial sequences were identiﬁed by comparison with the
sequences in the ENSEMBL (release 72) and NCBI (8 April 2013) databases,
respectively. In brief, all libraries were aligned to the Canis lupus familiaris genome
using SOAPaligner v.2.21 (http://soap.genomics.org.cn/soapaligner.html) and reads
that mapped to the genome removed. To remove bacterial sequences, one million
randomly selected reads per library were aligned (Z80% of read length andZ90%
sequence identity in overlapping regions) to known bacterial genomes using
BLAST v.2.2.26; low complexity reads were not aligned.
Transcriptome assembly. Pre-processed RNA-seq reads were assembled de novo
using the program Trinity (v.r2012-06-08)51 and also employing a genome-guided
approach employing the programs TopHat2 v.2.0.7 (ref. 52) and Cufﬂinks2 v.2.1.1
(ref. 53). First, to achieve a consensus (non-redundant) set of transcripts, the open
reading frames (ORFs) of all transcripts were predicted. Second, a single transcript
with the longest ORF was retained, if another transcript mapped to the same exon
in the reference genome and shared the same reading frame, and if the length of the
exonic (coding) regions covered by both transcripts divided by length of the
shortest ORF was 430%. Both genome-guided and de novo-assembled
transcriptomes for individual stages and tissues of T. canis were used for the
prediction of genes.
Genome assembly. Pre-processed genomic PE-libraries (insert sizes 170-, 500-
and 800-bp) and J-libraries (insert sizes: 2-, 5 -and 10-kb) were assembled and
scaffolded using the program SOAPdenovo2 v.2.04 (http://soap.genomics.org.cn/
soapdenovo.html) using a k-mer of 43. The GapCloser v.1.10 program within the
SOAPdenovo2 suite was used to close gaps in the scaffolded assembly. The com-
pleteness of the T. canis draft genome assembly was estimated using the program
CEGMA and the number of core eukaryotic genes54.
Prediction of repetitive elements. First, repeat sequences were masked using the
programs LTR_FINDER v.1.0.5 (ref. 55), PILER v.1.0 (ref. 56), RepeatScout v.1.0.5
(ref. 57), RepeatMasker v.open-4.0.3 (ref. 58) and Tandem Repeat Finder v.4.07
(ref. 59) using a collection of known repeats in Repbase v.17.02 (ref. 60). Then, all
transposons were combined and a non-redundant set of representative transposons
produced by selecting the longest transposon (representing each subclass) that
overlapped in sequence by 430% with the shortest transposon.
Identiﬁcation and annotation of non-coding regions and protein-coding genes.
The T. canis protein-coding genes were predicted de novo from the repeat-masked
draft genome and also using homology- and RNA-seq-based approaches against
the unmasked genome. The predictions were then merged into a non-redundant
gene set using the program GLEAN61. The training gene set for the de novo
predictions was inferred from transcriptomes assembled using the program
Cuffmerge v.2.1.1 (ref. 53). First, for each locus with multiple transcripts, only the
longest ORF was retained. Second, protein sequences inferred from the longest
ORFs in the resultant, non-redundant data set were aligned to the NCBI nr
database (released on 4 September 2013) using the program BLASTp. Matches that
aligned over 480% of their length both in reference and query and had 475%
identity represented the training set for the de novo gene-prediction programs
AUGUSTUS62, GlimmerHMM63 and SNAP64. Using each of these programs,
a gene set was predicted de novo from the assembled draft genome. In addition,
RNA-seq-, EST- and homology-based gene sets were predicted, which were then,
together with de novo-predictions, subjected to analysis using the program GLEAN
to infer a reference set of genes for T. canis. UTR-regions were removed from
RNA-seq-based, genome-guided and de novo-assembled transcriptomes using an
in-house pipeline. The prediction of the EST data set of T. canis was aided by the
NCBI EST database (8 September 2014) using the program BLASTn v.2.2.26.
Homology-based comparisons were made with the proteomes of A. suum, B.
malayi, C. elegans and P. paciﬁcus. The reference gene set of T. canis was reﬁned by
using gene-prediction models supported by (i) both homology and RNA-seq
evidence (420 mapped reads); (ii) homology-based models only, with no frame-
shift mutations and an alignment length of Z50% of the query sequence; and
(iii) RNA-seq models only, but encoding proteins of Z120 amino acids in length.
UTRs from RNA-seq data were added to the gene predictions using TopHat2
v.2.0.7. Finally, genes inferred to encode peptides of Z50 amino acids were
preserved; genes predicted were represented by their coding and inferred amino
acid sequences.
Functional annotation of all predicted protein sequences. First, following the
prediction of the protein-coding gene set for T. canis, each inferred amino acid
sequence was assessed for conserved protein domains using InterProScan 5 Web
Services (http://www.ebi.ac.uk/Tools/pfa/iprscan5/) and InterPro 44.0 (http://
www.ebi.ac.uk/interpro/). Second, amino acid sequences were subjected to BLASTp
v.2.2.26 (E-valuer10 8) using the following protein databases: C. elegans in
WormBase WS240 (www.wormbase.org); Swiss-Prot and TrEMBL (released in
March 2013) within UniProtKB; (KEGG release 58); NCBI protein nr (released in
September 2013). On the basis of the KEGG BLAST matches, the KEGG BRITE
hierarchy was used to classify predicted proteins into families; each coding gene
was assessed against the known KO-term BLAST matches using a custom script;
these matches were collected to known protein families in KEGG BRITE deﬁned in
the KEGG Orthology Based Annotation System database. ES proteins were pre-
dicted using the programs Phobius (http://www.ebi.ac.uk/Tools/pfa/phobius/),
SignalP (http://www.cbs.dtu.dk/services/SignalP/) and TMHMM (http://www.
cbs.dtu.dk/services/TMHMM/). The predicted proteins were listed, as were their
annotations based on the conserved InterProScan domain matches with respective
gene ontology terms and then (successively) based on their homology matches
(E-value cut-off: r10 8) to proteins in: the Swiss-Prot, C. elegans, the KEGG,
NCBI nr and TrEMBL databases. Any predicted protein without a match
(E-value cut-off: r10 8) in at least one of these databases was designated an
hypothetical protein. The ﬁnal annotation for the protein-coding gene set of
T. canis is available for download at http://bioinfosecond.vet.unimelb.edu.au/
Tcanis. Structural modelling was conducted using the program Phyre (http://
www.sbg.bio.ic.ac.uk/phyre2/).
RNAi pathway prediction. The RNAi effectors were predicted by the program
BLAST v2.2.28 (E-valuer10 15) using internal protein database and a database of
effector sequences42. Predictions were veriﬁed against the ﬁnal functional
annotations for T. canis and with the inferred proteome of A. suum (WormBase;
WS230). For each gene, levels of transcription in different developmental stages
and tissues (gut and reproductive) were normalized using the trimmed mean of
M-values scale-normalization method65.
Differential transcription analysis and integrated enrichment. The analysis of
RNA-seq data representing different developmental stages, body parts and genders
of T. canis was conducted using the program edgeR (http://www.bioconductor.org/
packages/release/bioc/html/edgeR.html). Individual pre-processed PE RNA-seq
data sets (three replicates) were mapped to the predicted gene set using TopHat2
v.2.0.7. The numbers of reads that mapped to each gene were enumerated using the
program SAMtools66. For each replicate of each data set (sample), the resultant
read counts were used as input data for edgeR. The levels of differential
transcription were calculated based on pairwise comparisons among samples of
T. canis (that is, L3 versus female anterior; L3 versus male anterior; female anterior
versus female reproductive tract; male anterior versus male reproductive tract;
female reproductive tract versus male reproductive tract; female anterior versus
female gut; male anterior versus male gut; female gut versus male gut). Using
dispersion factors calculated in edgeR, the genes were considered differentially
transcribed if the fold change compared with the normalized read count data was
Z2, and the false discovery rate was r0.05. In addition, enrichment clusters of
signiﬁcantly differentially transcribed genes were deﬁned (Fisher’s exact test) and
an integrated analysis was conducted. Using a custom script, data linked to these
gene clusters were enriched from KEGG pathway and KEGG BRITE hierarchy
database. Hubs of these gene clusters were identiﬁed using functional gene
networking (C. elegans; http://geneorienteer.org/) and weighted gene co-expression
network analysis67,68.
Orthology. First, orthologs were predicted by pairwise comparison of individual
proteins (predicted from each gene set) among T. canis, A. suum, B. malayi,
C. elegans and P. paciﬁcus using the OrthoMCL v.1.4 (ref. 69) and BLASTp (cut-
off: 10 5). Results obtained using these two approaches were displayed in a Venn
diagram.
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Prediction of essential molecules. Essential genes/gene products were
predicted70, but using reciprocal best BLAST hits to infer orthologous groups.
Lethal phenotypes (WBPhenotype:0000062 and sub-phenotypes (listed in http://
www.berkeleybop.org/ontologies/wbphenotype.obo) in C. elegans were identiﬁed in
WormBase WS240. Network connectivity data for C. elegans were obtained using
WormNet v.2 (http://www.functionalnet.org/wormnet/cgi-perl/WormNet.v2_
nga_form.cgi).
Additional analyses, and use of software for document preparation. We
conducted analyses in a Unix environment or Microsoft Excel 2007 using standard
commands. Bioinformatic scripts required to facilitate data analysis were designed
using mainly the Python2.6 scripting language and are available via http://
research.vet.unimelb.edu.au/gasserlab/.
References
1. Hotez, P. J., Fenwick, A., Savioli, L. & Molyneux, D. H. Rescuing the bottom
billion through control of neglected tropical diseases. Lancet 373, 1570–1575
(2009).
2. Crompton, D. W. Ascaris and ascariasis. Adv. Parasitol. 48, 285–375 (2001).
3. Hotez, P. J. & Wilkins, P. P. Toxocariasis: America’s most common neglected
infection of poverty and a helminthiasis of global importance? PLoS Negl. Trop.
Dis. 3, e400 (2009).
4. Hotez, P. J., Dumonteil, E., Hefferman, M. J. & Bottazzi, M. E. Innovation for
the ‘bottom 100 million’: eliminating neglected tropical diseases in the
Americas. Adv. Exp. Med. Biol. 764, 1–12 (2013).
5. Gasser, R. B. A perfect time to harness advanced molecular technologies to
explore the fundamental biology of Toxocara species. Vet. Parasitol. 193,
353–364 (2013).
6. Macpherson, C. N. The epidemiology and public health importance of
toxocariasis: a zoonosis of global importance. Int. J. Parasitol. 43, 999–1008
(2013).
7. Rubinsky-Elefant, G., Hirata, C. E., Yamamoto, J. H. & Ferreira, M. U. Human
toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of
the systemic and ocular forms. Ann. Trop. Med. Parasitol. 104, 3–23 (2010).
8. Pinelli, E., Brandes, S., Dormans, J., Gremmer, E. & van Loveren, H. Infection
with the roundworm Toxocara canis leads to exacerbation of experimental
allergic airway inﬂammation. Clin. Exp. Allergy 38, 649–658 (2008).
9. Overgaauw, P. A. & van Knapen, F. Veterinary and public health aspects of
Toxocara spp. Vet. Parasitol. 193, 398–403 (2013).
10. Akao, N. Critical Assessment of Existing and Novel Model Systems of
Toxocariasis. in Toxocara The Enigmatic Parasite (eds Holland, C. V. & Smith,
H. V.) 74–85 (CABI Publishing, 2006).
11. Schnieder, T., Laabs, E. M. & Welz, C. Larval development of Toxocara canis in
dogs. Vet. Parasitol. 175, 193–206 (2011).
12. Jex, A. R. et al. Ascaris suum draft genome. Nature 479, 529–533 (2011).
13. Wang, J. et al. Silencing of germline-expressed genes by DNA elimination in
somatic cells. Dev. Cell 23, 1072–1080 (2012).
14. Ghedin, E. et al. Draft genome of the ﬁlarial nematode parasite Brugia malayi.
Science 317, 1756–1760 (2007).
15. Dieterich, C. et al. The Pristionchus paciﬁcus genome provides a unique
perspective on nematode lifestyle and parasitism. Nat. Genet. 40, 1193–1198
(2008).
16. C. elegans Sequencing Consortium. Genome sequence of the nematode
C. elegans: a platform for investigating biology. Science 282, 2012–2018 (1998).
17. McKerrow, J. H., Caffrey, C., Kelly, B., Loke, P. & Sajid, M. Proteases in
parasitic diseases. Annu. Rev. Pathol 1, 497–536 (2006).
18. Hewitson, J. P., Grainger, J. R. & Maizels, R. M. Helminth immunoregulation:
the role of parasite secreted proteins in modulating host immunity. Mol.
Biochem. Parasitol. 167, 1–11 (2009).
19. Kaminsky, R., Mosimann, D., Sager, H., Stein, P. & Hosking, B. Determination
of the effective dose rate for monepantel (AAD 1566) against adult gastro-
intestinal nematodes in sheep. Int. J. Parasitol. 39, 443–446 (2009).
20. Wolstenholme, A. J., Fairweather, I., Prichard, R., von Samson-Himmelstjerna,
G. & Sangster, N. C. Drug resistance in veterinary helminths. Trends Parasitol.
20, 469–476 (2004).
21. Lespine, A., Menez, C., Bourguinat, C. & Prichard, R. K. P-glycoproteins and
other multidrug resistance transporters in the pharmacology of anthelmintics:
prospects for reversing transport-dependent anthelmintic resistance. Int. J.
Parasitol. Drugs Drug Resist. 2, 58–75 (2012).
22. Kru¨cken, J. et al. Anthelmintic cyclcooctadepsipeptides: complex in structure
and mode of action. Trends Parasitol. 28, 385–394 (2012).
23. Maizels, R. M. Toxocara canis: molecular basis of immune recognition and
evasion. Vet. Parasitol. 193, 365–374 (2013).
24. Maizels, R. M., Schabussova, I., Callister, D. M. & Nicoll, G. Molecular Biology
and Immunology of Toxocara canis. in Toxocara The Enigmatic Parasite. (eds
Holland, C. V. & Smith, H. V.) 3–17 (CABI Publishing, 2006).
25. Daniels, S. A., Ailion, M., Thomas, J. H. & Sengupta, P. egl-4 acts through a
transforming growth factor-beta/SMAD pathway in Caenorhabditis elegans to
regulate multiple neuronal circuits in response to sensory cues. Genetics 156,
123–141 (2000).
26. Crook, M. The dauer hypothesis and the evolution of parasitism: 20 years on
and still going strong. Int. J. Parasitol. 44, 1–8 (2014).
27. Wang, Z. et al. Gene expression analysis distinguishes tissue-speciﬁc and
gender-related functions among adult Ascaris suum tissues. Mol. Genet.
Genomics 288, 243–260 (2013).
28. Cantacessi, C. et al. A portrait of the "SCP/TAPS" proteins of eukaryotes–
developing a framework for fundamental research and biotechnological
outcomes. Biotechnol. Adv. 27, 376–388 (2009).
29. Newton, S. E. & Munn, E. A. The development of vaccines against
gastrointestinal nematode parasites, particularly Haemonchus contortus.
Parasitol. Today 15, 116–122 (1999).
30. Callister, D. M., Winter, A. D., Page, A. P. & Maizels, R. M. Four abundant
novel transcript genes from Toxocara canis with unrelated coding sequences
share untranslated region tracts implicated in the control of gene expression.
Mol. Biochem. Parasitol. 162, 60–70 (2008).
31. Othman, A. A. Therapeutic battle against larval toxocariasis: are we still far
behind? Acta Trop. 124, 171–178 (2012).
32. Shanmugam, D. et al. Integrating and Mining Helminth Genomes to Discover
and Prioritize Novel Therapeutic Targets. in Parasitic Helminths: Targets,
Scceens, Drugs and Vaccines (ed Caffrey, C. R.) 43–45 (Wiley-VCH Verlag Co.
KGaA, 2012).
33. Zhong, W. & Sternberg, P. W. Genome-wide prediction of C. elegans genetic
interactions. Science 311, 1481–1484 (2006).
34. Lee, I. et al. A single gene network accurately predicts phenotypic effects of gene
perturbation in Caenorhabditis elegans. Nat. Genet. 40, 181–188 (2008).
35. Campbell, B. E. et al. Atypical (RIO) protein kinases from Haemonchus
contortus - Promise as new targets for nematocidal drugs. Biotechnol. Adv. 29,
338–350 (2011).
36. Lipinski, C. A. Lead- and drug-like compounds: the rule-of-ﬁve revolution.
Drug Discov. Today: Technol. 1, 337–341 (2004).
37. Gaulton, A. et al. ChEMBL: a large-scale bioactivity database for drug
discovery. Nucleic Acids Res. 40, D1100–D1107 (2012).
38. Campbell, W. C., Fisher, M. H., Stapley, E. O., Albers-Schonberg, G. &
Jacob, T. A. Ivermectin: a potent new antiparasitic agent. Science 221, 823–828
(1983).
39. Keiser, J. & Utzinger, J. The drugs we have and the drugs we need against major
helminth infections. Adv. Parasitol. 73, 197–230 (2010).
40. Campbell, B. E. et al. Norcantharidin analogues with nematocidal activity in
Haemonchus contortus. Bioorg. Med. Chem. Lett. 21, 3277–3281 (2011).
41. de Savigny, D. H. In vitro maintenance of Tococara canis larvae and a simple
method for the production of Toxocara ES antigen for use in serodiagnosis test
for visceral larva migrans. J. Parasitol. 61, 781–782 (1975).
42. Dalzell, J. J. et al. RNAi effector diversity in nematodes. PLoS Negl. Trop. Dis. 5,
e1176 (2011).
43. McEwan, D. L., Weisman, A. S. & Hunter, C. P. Uptake of extracellular
double-stranded RNA by SID-2. Mol. Cell 47, 746–754 (2012).
44. Xu, M. J. et al. RNAi-mediated silencing of a novel Ascaris suum gene
expression in infective larvae. Parasitol. Res. 107, 1499–1503 (2010).
45. Chen, N. et al. Ascaris suum: RNAi mediated silencing of enolase gene
expression in infective larvae. Exp. Parasitol. 127, 142–146 (2011).
46. Robinson, L. N. et al. Harnessing glycomics technologies: integrating
structure with function for glycan characterisation. Electrophoresis 33, 797–814
(2012).
47. Sprent, J. F. Observations on the development of Toxocara canis (Werner,
1782) in the dog. Parasitology 48, 184–209 (1958).
48. Carlsgart, J., Roepstorff, A. & Nejsum, P. Multiplex PCR on single
unembryonated Ascaris (roundworm) eggs. Parasitol. Res. 104, 939–943 (2009).
49. Baermann, G. Eine einfache Methode zur Aufﬁndung von Ankylostomum
(Nematoden) Larven in Erdproben. Geneesk. Tijdschr. Ned.-Indie¨ 57, 131–137
(1917).
50. Jacobs, D. E., Zhu, X.-Q, Gasser, R. B. & Chilton, N. B. PCR-based methods for
identiﬁcation of potentially zoonotic ascaridoid parasites of the dog, fox and
cat. Acta Trop. 68, 191–200 (1997).
51. Grabherr, M. G. et al. Full-length transcriptome assembly from RNA-Seq data
without a reference genome. Nat. Biotechnol. 29, 644–652 (2011).
52. Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of
insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
53. Trapnell, C. et al. Transcript assembly and quantiﬁcation by RNA-Seq reveals
unannotated transcripts and isoform switching during cell differentiation. Nat.
Biotechnol. 28, 511–515 (2010).
54. Parra, G., Bradnam, K., Ning, Z., Keane, T. & Korf, I. Assessing the gene space
in draft genomes. Nucleic Acids Res. 37, 289–297 (2009).
55. Xu, Z. & Wang, H. LTR_FINDER: an efﬁcient tool for the prediction of
full-length LTR retrotransposons. Nucleic Acids Res. 35, W265–W268 (2007).
56. Edgar, R. C. & Myers, E. W. PILER: identiﬁcation and classiﬁcation of genomic
repeats. Bioinformatics 21(Suppl 1): i152–i158 (2005).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7145 ARTICLE
NATURE COMMUNICATIONS | 6:6145 | DOI: 10.1038/ncomms7145 |www.nature.com/naturecommunications 7
& 2015 Macmillan Publishers Limited. All rights reserved.
57. Price, A. L., Jones, N. C. & Pevzner, P. A. De novo identiﬁcation of repeat
families in large genomes. Bioinformatics. 21(Suppl 1): i351–i358 (2005).
58. Smit, A. F. A., Hubley, R. & Green, P. RepeatMasker Open-3.0. (1996-2010).
59. Benson, G. Tandem repeats ﬁnder: a program to analyze DNA sequences.
Nucleic Acids Res. 27, 573–580 (1999).
60. Jurka, J. et al. Repbase Update, a database of eukaryotic repetitive elements.
Cytogenet. Genome. Res. 110, 462–467 (2005).
61. Elsik, C. G. et al. Creating a honey bee consensus gene set. Genome. Biol. 8, R13
(2007).
62. Stanke, M., Tzvetkova, A. & Morgenstern, B. AUGUSTUS at EGASP: using
EST, protein and genomic alignments for improved gene prediction in the
human genome. Genome. Biol. 7(Suppl 1): S1.1–8 (2006).
63. Majoros, W. H., Pertea, M. & Salzberg, S. L. TigrScan and GlimmerHMM: two
open source ab initio eukaryotic gene-ﬁnders. Bioinformatics 20, 2878–2879
(2004).
64. Korf, I. Gene ﬁnding in novel genomes. BMC Bioinformatics 5, 59 (2004).
65. Robinson, M. D. & Oshlack, A. A scaling normalization method for differential
expression analysis of RNA-seq data. Genome. Biol. 11, R25 (2010).
66. Li, H. et al. The Sequence Alignment/Map format and SAMtools.
Bioinformatics 25, 2078–2079 (2009).
67. Zhang, B. & Horvath, S. A general framework for weighted gene co-expression
network analysis. Stat. Appl. Genet. Mol. Biol. 4, Article 17 (2005).
68. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation
network analysis. BMC Bioinformatics 9, 559 (2008).
69. Li, L., Stoeckert, Jr. C. J. & Roos, D. S. OrthoMCL: identiﬁcation of ortholog
groups for eukaryotic genomes. Genome. Res. 13, 2178–2189 (2003).
70. Doyle, M. A., Gasser, R. B., Woodcroft, B. J., Hall, R. S. & Ralph, S. A. Drug
target prediction and prioritization: using orthology to predict essentiality in
parasite genomes. BMC Genomics 11, 222 (2010).
Acknowledgements
This project was funded by the International Science & Technology Cooperation
Program of China (grant no. 2013DFA31840; X.-Q.Z. and R.B.G.), the Australian
Research Council (ARC) and the National Health and Medical Research Council
(NHMRC) of Australia (R.B.G.); it was also supported by a Victorian Life Sciences
Computation Initiative (VLSCI) grant (VR0007; R.B.G.) on its Peak Computing Facility
at the University of Melbourne, an initiative of the Victorian Government. Other support
from the Australian Academy of Science, Alexander von Humboldt Foundation and
Melbourne Water Corporation is gratefully acknowledged. N.D.Y. is an NHMRC Early
Career Research (ECRF) Fellow. We acknowledge the contributions of all the staff
members at WormBase (www.wormbase.org). We thank the Howard Hughes Medical
Institute (HHMI) and the National Institutes of Health (NIH; P.W.S.). We thank
BGI-Shenzhen for providing a commercial service for the construction of RNA-seq and
genomic libraries, and for sequencing.
Author contributions
P.N. collected and prepared T. canis materials. N.D.Y. and R.B.G. isolated genomic DNA
and RNA. P.K.K., N.D.Y. and R.B.G. designed and planned the study, which represents a
major part of P.K.K.’s PhD project. X.W. was responsible for sequencing. H.C. and
P.K.K. undertook the assembly, annotation and analyses, with support from N.D.Y., Q.L.,
J.M., Y.Y., R.S.H. and A.R.J.; P.K.K. and R.B.G. wrote the manuscript, with inputs from
other co-authors (N.D.Y., P.N., A.R.J., G.v.S.-H., A.H., P.T., P.W.S., X.F. and X.-Q.Z.).
R.B.G., P.K.K. and N.D.Y. supervised the project. X.-Q.Z. and R.B.G. raised the funds.
Additional information
Accession codes: Sequence data are accessible via National Center for Biotechnology
Information (NCBI; www.ncbi.nlm.nih.gov) under accession code JPKZ00000000 (ver-
sion JPKZ00000000.1; GI:734563511; BioProject: PRJNA248777).
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Zhu, X.-Q. et al. Genetic blueprint of the zoonotic pathogen
Toxocara canis. Nat. Commun. 6:6145 doi: 10.1038/ncomms7145 (2015).
This work is licensed under a Creative Commons Attribution-
NonCommercial-ShareAlike 4.0 International License. The images or
other third party material in this article are included in the article’s Creative Commons
license, unless indicated otherwise in the credit line; if the material is not included under
the Creative Commons license, users will need to obtain permission from the license
holder to reproduce the material. To view a copy of this license, visit http://
creativecommons.org/licenses/by-nc-sa/4.0/
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7145
8 NATURE COMMUNICATIONS | 6:6145 |DOI: 10.1038/ncomms7145 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
